tiprankstipranks
pc:loqus

LoQus23 Therapeutics Ltd

Building 522, Riverside Ivan de Burgh Room Cambridge, Cambridgeshire CB22 3AT, GB
https://www.loqus23.com/
LoQus23 Therapeutics Ltd is a biotechnology company focused on developing small molecule drugs aimed at halting DNA instability and slowing neurodegeneration in diseases such as Huntington's Disease and myotonic dystrophy type 1. The company is advancing its lead program targeting MutSβ, which is anticipated to enter clinical trials in 2026, offering a potentially disease-modifying therapy for these triplet repeat expansion diseases.

Leadership & Board

Current Number of Employees14
Current LinkedIn Followers2,099

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$35M
Total Amount Raised$35M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$35M
Latest Funding Amount$35M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

LoQus23 Therapeutics Ltd had 14 employees as of April 6, 2026. The number of employees increased by 0 (0.00%) week-over-week.
14Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

LoQus23 Therapeutics Ltd had 2,099 followers as of April 6, 2026. The number of followers increased by 7 (0.33%) week-over-week.
2,099Latest Followers Count
7(0.33%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Series A
$35.00M

Investors

Related News and Analysis